Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Kenvue Inc. Common Stock (KVUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Kenvue Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 5.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IOVA | KVUE | |
|---|---|---|
Market Cap | $6.04B | $34.06B |
Volume | 14,805,993 | 23,267,228 |
Sector | Health | Consumer Staples |
52-Week High | $14.82 | $19.83 |
52-Week Low | $1.81 | $14.11 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $5.97B | $41.56B |
Dividend Yield | — | 4.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →
